Business Context and Reporting Period
Entity discrepancy: The request identifies Spectral AI, Inc., but the supplied Form 10-Q is for Rosecliff Acquisition Corp I, a Delaware blank-check company (SPAC). This summary reflects the supplied filing, for the quarter ended June 30, 2021; it does not provide Spectral AI financial information.
Rosecliff had not commenced operations and reported no operating revenue. Its activity consisted of formation, its February 2021 IPO, and searching for a business combination. It raised $253.0 million in its IPO and placed that amount in a trust account. The company stated that it must complete a business combination by February 17, 2023 or redeem public shares and liquidate.
Financial Results and Position
- Revenue: None. Management said operating revenue would not be generated before a business combination.
- Three months ended June 30, 2021: Operating expenses were $287,037; net loss was $2,902,673. The loss primarily reflected a $2,628,000 increase in warrant-liability fair value, partly offset by $12,364 of trust-account interest.
- Six months ended June 30, 2021: Operating expenses were $444,853; net income was $318,968. Results included a $1,182,600 gain from the change in warrant fair value, $19,504 of trust interest, and $438,283 of transaction costs allocated to warrant liabilities.
- Cash and liquidity at June 30: Cash outside the trust was $868,692; trust assets were $253,019,504, primarily U.S. Treasury securities. Management reported working capital of approximately $1.1 million.
- Cash flow: The cash-flow statement reports $726,333 of cash used in operating activities for the six months. MD&A instead states $859,333; this discrepancy should be verified. Investing cash use was $253.0 million, and financing cash provided was $254.6 million.
- Liabilities and equity: Total liabilities were $19,742,161, including $10,643,400 of warrant liabilities and an $8,855,000 deferred underwriting fee payable only if a business combination closes. There was no long-term debt reported. Class A shares subject to possible redemption were presented as temporary equity at $229,642,450.
- Margins: Not meaningful because the company had no revenue or operating business.
Material Changes and Unusual Items
- The company completed its IPO and private placement in February 2021; the December 31, 2020 balance sheet therefore precedes these transactions.
- Following SEC staff guidance on SPAC warrants, the company classified public and private warrants as derivative liabilities, remeasured them at fair value each reporting period, and recorded changes in earnings. These non-cash changes drove much of the reported quarterly earnings volatility.
- The filing describes a correction to warrant accounting in the previously filed IPO-date balance sheet. Management identified a material weakness in internal control over financial reporting related to accounting for warrants; disclosure controls were deemed ineffective, and remediation was not complete as of June 30, 2021.
Outlook, Risks, and Contingencies
Management expected available working capital and potential sponsor or affiliate borrowing capacity to cover needs through a business combination or at least one year from issuance of the financial statements. Such loans were not committed. The company cautioned that it could need additional financing, including to complete a transaction or address significant shareholder redemptions.
Management cited uncertainty about COVID-19 effects on the company’s financial position and target search, with the specific impact not readily determinable. There was no assurance a business combination would be completed. Public shareholders could redeem shares in connection with a transaction; warrants could expire worthless if no transaction closes by the deadline. The company reported no legal proceedings and no material changes to previously disclosed risk factors beyond those discussed in this filing.
Important Facts to Verify
- Confirm the intended issuer: the supplied filing is for Rosecliff Acquisition Corp I, not Spectral AI, Inc.
- Reconcile operating cash used: $726,333 in the cash-flow statement versus $859,333 in MD&A.
- Review the warrant-liability valuation and resulting earnings volatility, including the accounting correction and related control weakness.
- Assess the company’s target-search progress, transaction financing needs, and redemption exposure against the February 17, 2023 deadline.